Archer: Enabling a paradigm shift in the way clinical trials are conducted

Archer：实现临床试验进行方式的范式转变

• 批准号: 10004435
• 金额: $ 44.56万
• 依托单位: IGNITE DATA LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2021
• 资助国家: 英国
• 起止时间: 2021 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10004435
• 关键词: Archer; Enabling; paradigm; shift; way

IgniteData is an exciting, fast-growing UK SME that uses data and technology to streamline key stages of the clinical research process. It provides world-leading software and consultancy services, including its clinical trial data management system, 'Archer', to facilitate the use of data in clinical investigations, ensure correct data transfer and validation and enable clinical studies to be carried out more quickly and cost-effectively.This project will accelerate the development and commercialisation of Archer, IgniteData's 'next-generation' cloud-based digital-health platform (termed a 'Software-as-a-Service' or SaaS). Archer is capable of remotely accessing and transforming patient medical records to enable the rapid, automated delivery of accurate, tracked and validated data to multiple research applications, including critical Covid-19 clinical research.Archer will provide real-time patient level insights to healthcare providers, and researchers. This innovation will allow the transfer of unstructured and structured data from EHRs in secondary care to clinical trial EDC platforms, replacing the manual transcription methods that currently lead to significant time delays, errors and additional costs.

IgniteData是一家令人兴奋的、快速增长的英国中小企业，它使用数据和技术来简化临床研究过程的关键阶段。它提供世界领先的软件和咨询服务，包括其临床试验数据管理系统‘Archer’，以促进在临床研究中使用数据，确保正确的数据传输和验证，并使临床研究能够更快、更具成本效益地进行。该项目将加快IgniteData基于云计算的下一代数字健康平台Archer的开发和商业化(称为‘软件即服务’或SaaS)。Archer能够远程访问和转换患者的医疗记录，以实现向多个研究应用程序(包括关键的新冠肺炎临床研究)快速、自动地提供准确、跟踪和验证的数据。Archer将向医疗保健提供商和研究人员提供实时的患者级别洞察。这项创新将允许将非结构化和结构化数据从二级护理中的EHR转移到临床试验EDC平台，取代目前导致显著时间延迟、错误和额外成本的手动转录方法。